These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9669294)

  • 1. The measurement of change in Graves' ophthalmopathy.
    Gorman CA
    Thyroid; 1998 Jun; 8(6):539-43. PubMed ID: 9669294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV; Toth J; Kaldi I; Damjanovich J; Mezosi E; Lenkey A; Toth L; Szabo J; Karanyi Z; Leovey A
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Graves' ophthalmopathy].
    Badelon I; Morax S
    Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
    de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between NMR scans of extraocular muscles and clinical symptoms in Graves' ophthalmopathy.
    Troelstra A; Rijneveld WJ; Kooijman AC; Houtman WA
    Doc Ophthalmol; 1988; 70(2-3):243-9. PubMed ID: 3234192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
    Szucs-Farkas Z; Toth J; Kollar J; Galuska L; Burman KD; Boda J; Leovey A; Varga J; Ujhelyi B; Szabo J; Berta A; Nagy EV
    Thyroid; 2005 Feb; 15(2):146-51. PubMed ID: 15753674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography.
    Yamamoto K; Itoh K; Yoshida S; Saito K; Sakamoto Y; Matsuda A; Saito T; Kuzuya T
    Endocrinol Jpn; 1979 Apr; 26(2):255-61. PubMed ID: 582582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE; Levin L
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' ophthalmopathy: I. Simple CT estimates of extraocular muscle volume.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):674-7. PubMed ID: 3179254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologically mediated cytotoxicity against human eye muscle cells in Graves' ophthalmopathy.
    Wang PW; Hiromatsu Y; Laryea E; Wosu L; How J; Wall JR
    J Clin Endocrinol Metab; 1986 Aug; 63(2):316-22. PubMed ID: 3755139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis and treatment of the ophthalmopathy associated with Graves' disease.
    Velkeniers B; Salu P
    Bull Soc Belge Ophtalmol; 1992; 245():9-14. PubMed ID: 1344754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
    Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
    Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiotherapy for Graves' ophthalmopathy: results at one year.
    Gorman CA
    Thyroid; 2002 Mar; 12(3):251-5. PubMed ID: 11952049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motility disturbances in Graves' ophthalmopathy.
    de Waard R; Koornneef L; Verbeeten B
    Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.
    Bartalena L; Marcocci C; Chiovato L; Laddaga M; Lepri G; Andreani D; Cavallacci G; Baschieri L; Pinchera A
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1139-44. PubMed ID: 6341388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.